ESMO 2014

Area: Oncology

Location: Madrid, Spain

Date: September 26 to September 30

Description:

European Society for Medical Oncology.


Search in Scientific Content:
Date
Filters:
Vemurafeni...
7:14

Vemurafenib vs. vemurafenib + cobimetinib in previously untreated BRAFV600–positive advanced melanoma

Presenter: Grant McArthur
Oncology
Neoadjuvan
5:04

Neoadjuvant chemo and extrapleural pneumonectomy of malignant pleural mesothelioma +/- hemithoracic radiotherapy: SAKK17/04 trial

Presenter: Rolf Stahel
Oncology
ESMO Exper
6:01

ESMO Expert on Lung Cancer: Novelties of ESMO 2104

Presenter: Stefan Zimmermann
Oncology
The IMELDA
5:54

The IMELDA and TANIA trials

Presenter: Joseph Gligorov
Oncology
ESMO Exper
8:17

ESMO Expert on Breast Cancer: Breast cancer trial presentations of the congress

Presenter: Evandro de Azambuja
Oncology
ESMO Exper
6:33

ESMO Expert on GI Tumours: Novelties of colorectal cancer treatment

Presenter: Eric Van Cutsem
Oncology
Vemurafeni
4:41

Vemurafenib + cobimetinib in BRAFV600-positive advanced melanoma: the coBRIM trial

Presenter: Grant McArthur
Oncology
Nivolumab
17:39

Nivolumab vs. chemotherapy in patients with advanced melanoma after prior anti-CTLA-4 therapy: the CHECKMATE 037 trial

Presenter: Jeffrey Weber
Oncology
ESMO Exper
8:12

ESMO Expert on Lung Cancer: What are the new results in lung cancer treatment?

Presenter: Floriana Morgillo
Oncology
Precision
2:18

Precision Medicine

Presenter: Solange Peters
Oncology
Profession
4:15

Professional burnout in European Young Oncologists: a serious risk for doctors and patients alike?

Presenter: Susana Banerjee
Oncology
ESMO's tas
6:25

ESMO's tasks and improving cancer drug reimbursement in Europe

Presenter: Rolf Stahel
Oncology
ESMO 2014
6:59

ESMO 2014 Highlights: Melanoma and colorectal cancer are the main field of progress

Presenter: Johann de Bono
Oncology
Cancer dur
5:24

Cancer during pregnancy

Presenter: Frederic Amant
Oncology
Afatinib v
5:29

Afatinib vs. methotrexate as second-line treatment for rec/met head&neck squamous cell carcinoma

Presenter: Jean-Pascal Machiels
Oncology
Anamorelin
5:06

Anamorelin for the treatment of cancer anorexia-cachexia in NSCLC: results from the Phase 3 studies ROMANA 1 and 2

Presenter: David Currow
Oncology

ICML 2017

2017-06-14 - 2017-06-17
Lugano, Switzerland

ASCO 2017

2017-06-02 - 2017-06-06
Chicago, United States

SABCS 2016

2016-12-06 - 2016-12-10
San Antonio, United States

ESMO 2016

2016-10-07 - 2016-10-11
Copenhagen, Denmark

ASCO 2016

2016-06-03 - 2016-06-07
Chicago, United States

ELCC 2016

2016-04-13 - 2016-04-16
Geneva, Switzerland

ESMO ECCO 2015

2015-09-25 - 2015-09-29
Vienna, Austria

ASCO 2015

2015-05-29 - 2015-06-02
Chicago, United States

ELCC 2015

2015-04-15 - 2015-04-18
Geneva, Switzerland